Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: Analysis of data from the MEGA Study, a large randomized controlled trial
Authors:
- Shinichiro UchiyamaSUShinichiro Uchiyama
- Noriaki NakayaNNNoriaki Nakaya
- Kyoichi MizunoKMKyoichi Mizuno
- Yasuo OhashiYOYasuo Ohashi
- Naoko TajimaNTNaoko Tajima
- Toshio KushiroTKToshio Kushiro
- Tamio TeramotoTTTamio Teramoto
- Haruo NakamuraHNHaruo Nakamura
- MEGA Study GroupMGMEGA Study Group
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 284 (1-2) , 72-76
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Lipid levels and the risk of ischemic stroke in womenNeurology, 2007
- Lipoprotein(a) and Incident Ischemic StrokeStroke, 2006
- Design and Baseline Characteristics of a Study of Primary Prevention of Coronary Events With Pravastatin Among Japanese With Mildly Elevated Cholesterol LevelsCirculation Journal, 2004
- Trends in the Incidence, Mortality, and Survival Rate of Cardiovascular Disease in a Japanese CommunityStroke, 2003
- Plasma Lipid Profile and Incident Ischemic StrokeStroke, 2003
- Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) TrialCirculation, 2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Incidence and Risk Factors for Stroke in an Occupational CohortStroke, 1998
- The Impact of Alcohol and Hypertension on Stroke Incidence in a General Japanese PopulationStroke, 1995
- Stroke in the Diabetic PatientDiabetes Care, 1994